Literature for peptidase S01.531: protein FAM111B
(Topics flags: K Knockout, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Naicker,D., Rhoda,C., Sunda,F. and Arowolo,A.
Unravelling the Intricate Roles of FAM111A and FAM111B: From Protease-Mediated Cellular Processes to Disease Implications
Int J Mol Sci25, PubMed Europe PubMed DOI V -
Huang,N., Peng,L., Yang,J., Li,J., Zhang,S. and Sun,M.
FAM111B Acts as an Oncogene in Bladder Cancer
Cancers (Basel)15, PubMed Europe PubMed DOI K -
Kliszczak,M., Moralli,D., Jankowska,J.D., Bryjka,P., Subha Meem,L., Goncalves,T., Hester,S.S., Fischer,R., Clynes,D. and Green,C.M.
Loss of FAM111B protease mutated in hereditary fibrosing poikiloderma negatively regulates telomere length
Front Cell Dev Biol11, 1175069-1175069. PubMed Europe PubMed DOI -
Ryabets-Lienhard,A., Panjawatanan,P., Vogt,K., Ji,J., Georgia,S. and Pitukcheewanont,P.
A Novel De Novo Frameshift Pathogenic Variant in the FAM111B Resulting in Progressive Osseous Heteroplasia Phenotype
Calcif Tissue Int112, 518-523. PubMed Europe PubMed DOI -
Wu,H. and Liang,C.
Pan-Cancer Analysis of the Tumorigenic Effect and Prognostic Diagnostic Value of FAM111B in Human Carcinomas
Int J Gen Med16, 1845-1865. PubMed Europe PubMed DOI K -
Arowolo,A., Rhoda,C. and Khumalo,N.
Mutations within the putative protease domain of the human FAM111B gene may predict disease severity and poor prognosis: A review of POIKTMP cases
Exp Dermatol31, 648-654. PubMed Europe PubMed DOI -
Welter,A.L. and Machida,Y.J.
Functions and evolution of FAM111 serine proteases
Front Mol Biosci9, 1081166-1081166. PubMed Europe PubMed DOI V -
Ip,W.H., Wilkens,B., Solomatina,A., Martin,J., Melling,M., Hidalgo,P., Bertzbach,L.D., Speiseder,T. and Dobner,T.
Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes
Viruses13, PubMed Europe PubMed DOI K -
Hoffmann,S., Pentakota,S., Mund,A., Haahr,P., Coscia,F., Gallo,M., Mann,M., Taylor,N.M. and Mailand,N.
FAM111 protease activity undermines cellular fitness and is amplified by gain-of-function mutations in human disease
EMBO Repe50662-e50662. PubMed Europe PubMed DOI -
Mercier,S., Küry,S., Shaboodien,G., Houniet,D.T., Khumalo,N.P., Bou-Hanna,C., Bodak,N., Cormier-Daire,V., David,A., Faivre,L., Figarella-Branger,D., Gherardi,R.K., Glen,E., Hamel,A., Laboisse,C., Le,C.a., Lindenbaum,P., Magot,A., Munnich,A., Mussini,J.M., Pillay,K., Rahman,T., Redon,R., Salort-Campana,E., Santibanez-Koref,M., Thauvin,C., Barbarot,S., Keavney,B., Bézieau,S. and Mayosi,B.M.
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis
Am J Hum Genet93, 1100-1107. DOI
2024
2023
2022
2021
2020
2013
